FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

RF Kaiko

Research Profile

Chemicals & Drugs

Procedures

Concepts & Ideas

Disorders

Activities & Behaviors

Patient Acceptance of Health Care

Physiology

Intestinal Absorption

Co-author Network

Publications

TOP 3
Winston C V Parris; Benjamin W Johnson; M K Croghan; M R Moore; A Khojasteh; Robert F Reder; RF Kaiko; Barbara J Buckley
The use of controlled-release oxycodone for the treatment of chronic cancer pain: a randomized, double-blind study.
Ronald Kaplan; Winston C V Parris; M L Citron; Donna S Zhukovsky; Robert F Reder; Barbara J Buckley; RF Kaiko
Comparison of controlled-release and immediate-release oxycodone tablets in patients with cancer pain.
P Mucci-LoRusso; B S Berman; P T Silberstein; M L Citron; Linda Bressler; S M Weinstein; RF Kaiko; B J Buckley; Robert F Reder
Controlled-release oxycodone compared with controlled-release morphine in the treatment of cancer pain: a randomized, double-blind, parallel-group study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of RF Kaiko (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

1998: Winston C V Parris; Benjamin W Johnson; M K Croghan; M R Moore; A Khojasteh; Robert F Reder; RF Kaiko; Barbara J Buckley
The use of controlled-release oxycodone for the treatment of chronic cancer pain: a randomized, double-blind study.
Journal of pain and symptom management 1998;16(4):205-11.
1998: Ronald Kaplan; Winston C V Parris; M L Citron; Donna S Zhukovsky; Robert F Reder; Barbara J Buckley; RF Kaiko
Comparison of controlled-release and immediate-release oxycodone tablets in patients with cancer pain.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(10):3230-7.
1998: P Mucci-LoRusso; B S Berman; P T Silberstein; M L Citron; Linda Bressler; S M Weinstein; RF Kaiko; B J Buckley; Robert F Reder
Controlled-release oxycodone compared with controlled-release morphine in the treatment of cancer pain: a randomized, double-blind, parallel-group study.
European journal of pain (London, England) 1998;2(3):239-49.
1998: M L Citron; Ronald Kaplan; Winston C V Parris; M K Croghan; L H Herbst; R J Rosenbluth; Robert F Reder; N S Slagle; Barbara J Buckley; RF Kaiko
Long-term administration of controlled-release oxycodone tablets for the treatment of cancer pain.
Cancer investigation 1998;16(8):562-71.
1997: RF Kaiko
The effect of food intake on the pharmacokinetics of sustained-release morphine sulfate capsules.
Clinical therapeutics 1997;19(2):296-303.
1996: JW Mandema; RF Kaiko; B Oshlack; Robert F Reder; Donald R Stanski
Characterization and validation of a pharmacokinetic model for controlled-release oxycodone.
British journal of clinical pharmacology 1996;42(6):747-56.
1996: Abraham Sunshine; NZ Olson; A Colon; J Rivera; RF Kaiko; R D Fitzmartin; Robert F Reder; P D Goldenheim
Analgesic efficacy of controlled-release oxycodone in postoperative pain.
Journal of clinical pharmacology 1996;36(7):595-603.
1996: D P Benziger; RF Kaiko; J B Miotto; R D Fitzmartin; Robert F Reder; M Chasin
Differential effects of food on the bioavailability of controlled-release oxycodone tablets and immediate-release oxycodone solution.
Journal of pharmaceutical sciences 1996;85(4):407-10.
1996: Robert F Reder; B Oshlack; J B Miotto; D D Benziger; RF Kaiko
Steady-state bioavailability of controlled-release oxycodone in normal subjects.
Clinical therapeutics 1996;18(1):95-105.
1996: RF Kaiko; D P Benziger; R D Fitzmartin; B E Burke; Robert F Reder; P D Goldenheim
Pharmacokinetic-pharmacodynamic relationships of controlled-release oxycodone.
Clinical pharmacology and therapeutics 1996;59(1):52-61.
1995: E D Bashaw; RF Kaiko; R P Grandy; Robert F Reder; P D Goldenheim
Relative bioavailability of controlled-release oral morphine sulfate during naltrexone blockade.
International journal of clinical pharmacology and therapeutics 1995;33(9):524-9.
1995: RF Kaiko; R P Grandy; Robert F Reder; P D Goldenheim; R S Sackler
A bioequivalence study of oral controlled-release morphine using naltrexone blockade.
Journal of clinical pharmacology 1995;35(5):499-504.
1993: S S Bloomfield; G B Cissell; J Mitchell; T P Barden; RF Kaiko; R D Fitzmartin; R P Grandy; J Komorowski; P D Goldenheim
Analgesic efficacy and potency of two oral controlled-release morphine preparations.
Clinical pharmacology and therapeutics 1993;53(4):469-78.
1992: RF Kaiko; R D Fitzmartin; G B Thomas; P D Goldenheim
The bioavailability of morphine in controlled-release 30-mg tablets per rectum compared with immediate-release 30-mg rectal suppositories and controlled-release 30-mg oral tablets.
Pharmacotherapy 1992;12(2):107-13.
1989: RF Kaiko; R P Grandy; B Oshlack; J Pav; J Horodniak; G Thomas; E Ingber; P D Goldenheim
The United States experience with oral controlled-release morphine (MS Contin tablets). Parts I and II. Review of nine dose titration studies and clinical pharmacology of 15-mg, 30-mg, 60-mg, and 100-mg tablet strengths in normal subjects.
Cancer 1989;63(11 Suppl):2348-54.